State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT03524430 N/A
Recruiting
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized ...
Condition
Breast Neoplasm Female
Enrollment
801 pts
Location
United States, Canada, France
Sponsor
Rna Diagnostics Inc.
NCT05687123 Phase 1
Recruiting
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera)...
Condition
Metastatic Pancreatic Neuroendocrine Tumor
Enrollment
24 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05985161 Phase 2
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Condition
Wilms Tumor
Enrollment
45 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT07110454 N/A
Recruiting
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Condition
Epilepsy
Enrollment
210 pts
Location
United States
Sponsor
Epiminder America, Inc.
NCT05283720 Phase 2
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneou...
Condition
Non-Hodgkin Lymphoma
Enrollment
496 pts
Location
United States, China, Czechia
Sponsor
Genmab
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT06864754 N/A
Recruiting
WashU DIEP Flap Video and Patient Understanding Improvement
Condition
Breast Cancer
Enrollment
300 pts
Location
United States
Sponsor
Washington University School o
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
230 pts
Location
United States
Sponsor
Incyte Corporation
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06589245 Phase 1
Recruiting
Inhaled Ciclesonide Study in Preterm Infants
Condition
Bronchopulmonary Dysplasia
Enrollment
30 pts
Location
United States
Sponsor
Venkatesh Sampath
NCT06088654 Phase 1, Phase 2
Recruiting
Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgk...
Condition
Non Hodgkin Lymphoma
Enrollment
184 pts
Location
United States, Australia, France
Sponsor
Innate Pharma
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT06813820 N/A
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Condition
Left Ventricle Remodeling
Enrollment
135 pts
Location
United States
Sponsor
BioVentrix
NCT07397559 N/A
Recruiting
Spatiotemporal tSCS in Spinal Cord Injury
Condition
Spinal Cord Injuries (SCI)
Enrollment
48 pts
Location
United States
Sponsor
Washington University School o
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network